REFERENCES
- Dirix LY, Van Oosterom AT. Soft tissue sarcoma in adults. Curr Opin Oncol 1999; 11: 285–295.
- Attanoos RL, Appleton MA, Gibbs AR. Primary sarco-mas of the lung: a clinicopathological and immunohistochemi-cal study of 14 cases. Histopathology 1996; 29: 29–36.
- Moran CA, Suster S, Abbondanzo SL, Koss MN. Primary leiomyosarcomas of the lung: a clinicopathologic and immunohistochemical study of 18 cases. Mod Pathol 1997; 10: 121–128.
- Sekine I, Kodama T, Yokose T et al. Rare pulmonary tumors - a review of 32 cases. Oncology 1998; 55: 431–434.
- Keel SB, Bacha E, Mark EJ et al. Primary pulmonary sarcoma: a clinicopathologic study of 26 cases. Mod Pathol 1999; 12: 1124–1131.
- Porte HL, Metois DG, Leroy X et al. Surgical treatment of primary sarcoma of the lung. Eur J Cardiothorac Surg 2000; 18: 136–142.
- Magnè N, Porsin B, Pivot X et al. Primary lung sarco-mas: long survivors obtained with iterative complete surgery. Lung Cancer 2001; 31: 241–245.
- Plunkett W, Huang P, Xu YZ et al. Gemcitabine: metab-olism, mechanisms of action, and self-potentiation. Semin Oncol 1995; 22 (4 Suppl 11): 3-10.
- Woll PJ, Judson I, Lee SM et al. Temozolomide in adult patients with advanced soft tissue sarcoma: a phase II study of the EORTC Soft Tissue and Bone Sarcoma Group. Eur J Cancer 1999; 35: 410–412.
- Byrne K, Steward WP. The role of chemotherapy in the treatment of adult soft tissue sarcomas. Oncology 1999; 56: 13–23.
- Patel SR, Gandhi V, Jenkins J et al. Phase II clinical investigation of gemcitabine in advanced soft tissue sarcomas and window evaluation of dose rate on gemcitabine triphos-phate accumulation. J Clin Oncol 2001; 19: 3483–3489.
- Merimsky O, Meller I, Flusser G et al. Gemcitabine in soft tissue or bone sarcoma resistant to standard chemothera-py: a phase II study. Cancer Chemother Pharmacol 2000; 45: 177-181.
- Spath-Schwalbe E, Genvresse I, Koschuth A et al. Phase II trial of gemcitabine in patients with pretreated advanced soft tissue sarcomas. Anticancer Drugs 2000; 11: 325–329.
- Okuno S, Edmonson J, Mahoney M et al. Phase II trial of gemcitabine in advanced sarcomas. Cancer 2002; 94: 3225–3229.
- Svancàrovà L, Blay JY, Judson IR et al. Gemcitabine in advanced adult soft-tissue sarcomas. A phase II study of the EORTC Soft Tissue and Bone Sarcoma Group. Eur J Cancer 2002; 38: 556–559.